OrthoPediatrics Corp. (NASDAQ:KIDS) Shares Sold by Riverbridge Partners LLC

Riverbridge Partners LLC lessened its holdings in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 11.8% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 390,774 shares of the company’s stock after selling 52,295 shares during the quarter. Riverbridge Partners LLC owned about 1.61% of OrthoPediatrics worth $9,058,000 as of its most recent filing with the SEC.

Other institutional investors have also recently made changes to their positions in the company. Quarry LP purchased a new position in OrthoPediatrics in the third quarter valued at $25,000. International Assets Investment Management LLC boosted its stake in shares of OrthoPediatrics by 2,610.8% in the 3rd quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after buying an additional 966 shares during the period. BNP Paribas Financial Markets grew its position in shares of OrthoPediatrics by 125.1% during the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock worth $94,000 after buying an additional 1,929 shares in the last quarter. Quantbot Technologies LP increased its stake in shares of OrthoPediatrics by 42.2% during the third quarter. Quantbot Technologies LP now owns 5,773 shares of the company’s stock worth $157,000 after buying an additional 1,712 shares during the period. Finally, Deerfield Management Company L.P. Series C acquired a new stake in OrthoPediatrics in the second quarter valued at approximately $203,000. Institutional investors and hedge funds own 69.05% of the company’s stock.

OrthoPediatrics Trading Down 0.4 %

KIDS stock opened at $27.12 on Thursday. The company’s 50 day moving average is $24.15 and its two-hundred day moving average is $27.28. OrthoPediatrics Corp. has a twelve month low of $21.02 and a twelve month high of $35.99. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the stock. Needham & Company LLC reissued a “buy” rating and issued a $42.00 price objective on shares of OrthoPediatrics in a research report on Tuesday, January 14th. Truist Financial dropped their target price on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.